NeuroRx Sequential Therapy (NRX-100 Followed by NRX-101) for Treatment of Severe Bipolar Depression in Patients With Acute Suicidal Ideation and Behavior: The SBD-ASIB Study

Trial Profile

NeuroRx Sequential Therapy (NRX-100 Followed by NRX-101) for Treatment of Severe Bipolar Depression in Patients With Acute Suicidal Ideation and Behavior: The SBD-ASIB Study

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 12 Jan 2018

At a glance

  • Drugs Cycloserine/lurasidone (Primary) ; Ketamine; Lurasidone
  • Indications Bipolar depression; Suicidal ideation
  • Focus Therapeutic Use
  • Acronyms The SBD-ASIB Study
  • Sponsors NeuroRX
  • Most Recent Events

    • 12 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top